Kura Oncology, Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.91 | — | — | Miss |
| Q12026 FY2026 | $-0.88 | $-0.83 | +5.7% | Beat |
| 2026-02-25 | $-0.72 | — | — | Miss |
Back to KURA overview · KURA holders · KURA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.